HOT sale RT50 High-quality ,white powder china Tirzepatide Quality guarantee
7599 Inquiries
2381089-83-2
Pharmaceutical Grade
99%
shanghai
ZM
60mg per vial; 10vials/box
Yes
2033-09-02
GLP-1,Retatrutide,Selank,Tirzepatide
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceRetatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.Basic Info-
Product Name:
Retatrutide
Other Name:Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide
CAS No.:2381089-83-2
InChIKeys:MLOLQJNKXBNWFW-SAGGEDDASA-N
Molecular Weight:0
EC Number:200-001-8
Color/Form:White lyophilized
Categories:
Characteristics-
Water Solubility:
Soluble in water (5mg/ml).
Storage Conditions:-20°C
Critical Temperature & Pressure:-20°C
Research-
Class:
Triple agonist — GCGR, GIPR, GLP-1R
Status:Investigational (Phase 3)
Mechanism:Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.
EC50 (Human GCGR):5.79 nM
EC50 (Mouse GIPR):0.191 nM
EC50 (Mouse GLP1R):0.794 nM
EC50 (Mouse GCGR):2.32 nM
EC50 (Human GLP1R):0.775 nM
EC50 (Human GIPR):0.0643 nM
Source:Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI
Clinical Development:
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Literature:
NEJM: Jastreboff et al. (2023) — Phase 2 Trial ; FDA Drugs@FDA
Disclaimer:Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
GLP-1,Retatrutide,Selank,Tirzepatide
-
Location:
#704-A008, Building 11, Block 16, Liangzhu Street, Yuhang District, Hangzhou City, Zhejiang Province
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
1 days
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
51-100
-
Year of Establishment:
2025
-
-
Inquiry History7599 Inquiries
Country Product Purchase Quantity Date Posted
South Africa
Retatrutide
1 MT Nov 10, 2026
Australia
retatrutide
10 MG Nov 10, 2026
United States
Retatrutide
30 MG Nov 10, 2026
Canada
retatrutide
30 MG Nov 10, 2026
United States
retatrutide
20 MG Nov 10, 2026
Ireland
retatrutide
30 MG Nov 10, 2026
United States
Retatrutide
400 MG Nov 10, 2026
United States
Retatrutide
30 MG Nov 9, 2026
Canada
retatrutide
20 MG Nov 9, 2026
United States
Retatrutide
30 MG Nov 9, 2026
United States
retatrutide
30 MG Nov 9, 2026
United States
retatrutide
50 MG Nov 9, 2026
Turkey
retatrutide
30 MG Nov 9, 2026
United Kingdom
Retatrutide
100 MG Nov 9, 2026
United States
Retatrutide
10 MT Nov 9, 2026
United States
Retatrutide
60 MG Nov 9, 2026
Canada
Retatrutide
20 MG Nov 9, 2026
Australia
Retatrutide
1 MT Nov 8, 2026
Australia
Retatrutide
1 MT Nov 8, 2026
United States
Retatrutide
1 MT Nov 7, 2026 Post an enquiry for this product
More from this Seller
-
-
-
SLU-PP-322 99% High content white powder 5mg 10mg 30mg customization
Pharmaceutical Grade / 99%
$30/MT FOB
-
-
-
-
5mg 10mg 30mg Retatrutide 99% Peptides Vials Sema Tirz RT for Weight Loss Cagrilintide
Pharmaceutical Grade / 99%
$20/UNIT FOB
-
-
-
-
GHK-CU hot selling 99% Purity High Quality 50mg in stock
Pharmaceutical Grade / 99%
$30/UNIT FOB
-
-
-
-
Semaglutide | SM | 99% Purity | White Lyophilized Powder | Factory Wholesale | Export Goods
Pharmaceutical Grade / 99%
$34/UNIT FOB
-
-
-
-
Hot sell Tirzepatide TR100 100mg*10vialsall reta bc nad China Origin 99.0% Purity delta Sleep-Inducing Peptide DSIP
Pharmaceutical Grade / 99%
$30/UNIT FOB
-
-
-
-
20mg 99% Purity Cartalax CAS 45234-02-4 Raw Peptide Factory Supply High Low Price
Pharmaceutical Grade / 99%
$20/MT FOB
-
Product Detail